Team:Slovenia/Sponsors

From 2008.igem.org

(Difference between revisions)
 
(15 intermediate revisions not shown)
Line 78: Line 78:
<a href="https://2008.igem.org/Team:Slovenia/Background/The_problem" target="_self">The problem</a>
<a href="https://2008.igem.org/Team:Slovenia/Background/The_problem" target="_self">The problem</a>
<a href="https://2008.igem.org/Team:Slovenia/Background/Modern_vaccines" target="_self">Modern vaccines</a>
<a href="https://2008.igem.org/Team:Slovenia/Background/Modern_vaccines" target="_self">Modern vaccines</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Background/Immune_response" target="_self">Immune response</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Background/Flagellin" target="_self">Flagellin</a>
</div>
</div>
</li>
</li>
Line 94: Line 96:
<a href="https://2008.igem.org/Team:Slovenia/Results/Antigen-TLR_fusion_vaccine" target="_self">Antigen-TLR fusion vaccine</a>
<a href="https://2008.igem.org/Team:Slovenia/Results/Antigen-TLR_fusion_vaccine" target="_self">Antigen-TLR fusion vaccine</a>
<a href="https://2008.igem.org/Team:Slovenia/Results/Real-life_results" target="_self">"Real-life" results</a>
<a href="https://2008.igem.org/Team:Slovenia/Results/Real-life_results" target="_self">"Real-life" results</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Results/Biobricks" target="_self">Biobricks</a>
</div>
</div>
</li>
</li>
Line 104: Line 107:
<a href="https://2008.igem.org/Team:Slovenia/Notebook/Methods" target="_self">Methods</a>
<a href="https://2008.igem.org/Team:Slovenia/Notebook/Methods" target="_self">Methods</a>
<a href="https://2008.igem.org/Team:Slovenia/Notebook/Safety" target="_self">Safety</a>
<a href="https://2008.igem.org/Team:Slovenia/Notebook/Safety" target="_self">Safety</a>
-
<a href="https://2008.igem.org/Team:Slovenia/Notebook/Timeline" target="_self">Timeline</a>
 
<a href="https://2008.igem.org/Team:Slovenia/Notebook/References" target="_self">References</a>
<a href="https://2008.igem.org/Team:Slovenia/Notebook/References" target="_self">References</a>
-
                <a href="https://2008.igem.org/Team:Slovenia/Notebook/Biobricks" target="_self">Biobricks</a>
 
                 <a href="https://2008.igem.org/Team:Slovenia/Notebook/Notebook" target="_self">Notebook</a>
                 <a href="https://2008.igem.org/Team:Slovenia/Notebook/Notebook" target="_self">Notebook</a>
</div>
</div>
Line 160: Line 161:
-->
-->
<html><center>
<html><center>
-
<font size="-1" color="#C73E4A"><i><b>We would like to express our thanks to our sponsors:</b></i></font>  
+
<font size="5" color="#C73E4A"><i>We would like to express our thanks to our sponsors:</i></font>  
-
</center></html>
+
</center><br /></html>
Line 168: Line 169:
<html>
<html>
 +
<p>
       <table width="100%" border="0" cellspacing="25" cellpadding="1" align="center">
       <table width="100%" border="0" cellspacing="25" cellpadding="1" align="center">
           <tr>
           <tr>
Line 207: Line 209:
             <td><div align="center">
             <td><div align="center">
-
               <p><a href="http://www.ad-futura.si" target="_blank"><img src="https://static.igem.org/mediawiki/2008/f/f7/Mercator.jpg" width="150" height="100" /></a></p>
+
               <p><a href="http://www.ad-futura.si" target="_blank"><img src="https://static.igem.org/mediawiki/2008/3/38/Adfutura.gif" width="150" height="100" /></a></p>
               <p>&nbsp;Ad futura</p>
               <p>&nbsp;Ad futura</p>
             </div></td>
             </div></td>
-
           </tr>
+
 
 +
 
 +
 
 +
 
 +
           <td><div align="center">
 +
 
 +
              <p>
 +
 
 +
<img src="https://static.igem.org/mediawiki/2008/d/db/TollImmune.gif" width="300" height="62" />
 +
</p>
 +
              <p>&nbsp;</p>
 +
            </div></td>
 +
 
 +
 
 +
 
 +
 
 +
        </tr>
           <tr>
           <tr>
         </table>
         </table>
</html>
</html>
-
 
+
<html><center>
 +
Roche d.o.o, MEDILINE d.o.o, Anthron d.o.o., Lotrič d.o.o, Mercator d.d., Fementas, Micro+Polo
 +
</center><br/><br /></html>
----
----
Line 229: Line 249:
</tr>
</tr>
</table>
</table>
-
<map name="Map" id="Map">
+
</p>
-
<area shape="rect" coords="795,3,896,28" href="https://2008.igem.org/Team:Slovenia/Sponsors" target="_self" />
+
-
<area shape="rect" coords="66,-1,176,29" href="https://2008.igem.org/Team:Slovenia/Team" target="_self" />
+
-
<area shape="rect" coords="326,3,461,29" href="https://2008.igem.org/Team:Slovenia/Project" target="_self" />
+
-
<area shape="rect" coords="466,3,559,28" href="https://2008.igem.org/Team:Slovenia/Results" target="_self" />
+
-
<area shape="rect" coords="564,3,672,27" href="https://2008.igem.org/Team:Slovenia/Biobricks" target="_self" />
+
-
<area shape="rect" coords="678,2,789,28" href="https://2008.igem.org/Team:Slovenia/Notebook" target="_self" />
+
-
<area shape="rect" coords="2,2,60,29" href="https://2008.igem.org/Team:Slovenia" target="_self" />
+
-
<area shape="rect" coords="181,1,323,28" href="https://2008.igem.org/Team:Slovenia/Background" target="_self" />
+
-
</map>
+
</html>
</html>
<!------------------------------- KONEC IGEM 2008 STRANI ------------------------------------------------------>
<!------------------------------- KONEC IGEM 2008 STRANI ------------------------------------------------------>

Latest revision as of 11:13, 30 October 2008

Igem-logo-900x200-1-2.jpg



We would like to express our thanks to our sponsors:




 National Institute of Chemistry Slovenia

 University of Ljubljana

 Kemomed d.o.o.

 KRKA d.d, Novo mesto

 Lek - član skupine Sandoz

 Slovenian Research Agency

 Ad futura

 

Roche d.o.o, MEDILINE d.o.o, Anthron d.o.o., Lotrič d.o.o, Mercator d.d., Fementas, Micro+Polo